ASPECT
Aspirin after hospitalisation with Pneumonia to prevent cardiovascular Events randomised Controlled Trial
Study summary
A pneumonia trial – the largest ever – will investigate whether aspirin can reduce the risk of a heart attack or stroke in patients who are admitted to hospital with pneumonia. May: ASPECT research study | News and features | University of Bristol
The research study ‘Aspirin after hospitalisation with Pneumonia to prevent cardiovascular Events randomised Controlled Trial’ is being managed by the Bristol Trials Centre.
This randomised controlled trial is recruiting 22,600 patients from over 60 hospitals across England. Findings from the four-year study will support future treatment guidelines, if appropriate, for patients with pneumonia. If aspirin is shown to be effective it could prevent up to 3,000 heart attacks and strokes a year in England alone.
Further study details
- Chief Investigator: Nick Maskell